ICH quality guidelines
- Q8: pharmaceutical development and Quality by Design. Key terms: quality target product profile (QTPP), critical quality attributes (CQAs), critical process parameters (CPPs) and design space.
- Q9: quality risk management. Tools include FMEA, FMECA, fault tree analysis, HACCP, HAZOP and risk ranking; risk combines severity and probability (and detectability in FMEA's risk priority number).
- Q10: the Pharmaceutical Quality System across the product lifecycle: development, technology transfer, commercial manufacturing and discontinuation.
- Q10's four elements: process performance and product quality monitoring, CAPA, change management, and management review. Its two enablers: knowledge management and quality risk management.
- Related: Q7 (GMP for active ingredients), Q11 (drug substance development), Q12 (post-approval lifecycle management).